Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironmentsShogo Kumagai, Hiroyoshi Nishikawa, Genki Okumura et al.|Cancer Cell|2022Cited by 828
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Hiroyoshi Nishikawa, Yosuke Togashi et al.|Nature Immunology|2020Cited by 810
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancerEri Sugiyama, Hiroyoshi Nishikawa, Yosuke Togashi et al.|Science Immunology|2020Cited by 285
CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitorsMasayuki Ishibashi, Genichiro Ishii|Scientific Reports|2017Cited by 55